Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019;19(1):56 − 66. http://dx.doi.org/10.1016/S1473-3099(18)30605-4CrossRef
Public health France, University of Lorraine, AntibioEst, Regional Health Agency Grand Est, Primary Health Insurance Funds of Meurthe-et-Moselle, Regional Division of the North-East Medical Service. Antibio’Malin - Les antibiotiques: soyons malins, utilisons-les mieux. 2022. https://www.sante.fr/antibiomalin. [2022-04-03]. (In French).https://www.sante.fr/antibiomalin
France is a country with 67 million inhabitants and is part of the European Union. Antibiotic consumption in humans is higher in France as compared to the European average, especially in outpatient settings (1-2). The burden of antibiotic resistance is also high, as compared to the European average, with an estimated 5,500 deaths per year associated with multidrug-resistant bacterial infections (3). Encouraging results have, however, been observed over the last several years: antibiotic consumption in the community, in nursing homes and in hospitals showed a decreasing trend, as well as certain resistant bacteria, such as 3rd-generation cephalosporin- or fluoroquinolone-resistant Escherichia coli (1-2,4-5). The COVID-19 pandemic has had a dramatic impact on antibiotic consumption and its long-term impact on antibiotic resistance is being carefully monitored (1).
Antimicrobial resistance (AMR), in particular antibiotic resistance, is a long-standing priority for the French government. Action plans in human health coordinated by the Ministry of Health have been in place for more than 20 years, while plans in animal health have been coordinated by the Ministry of Agriculture since 2012 (6). The first Interministerial Committee for Health was dedicated to AMR, with a specific focus on antibiotic resistance. In November 2016, the French government adopted the Antibiotic Resistance Interministerial National Action Plan, using a One Health approach (7). This action plan is organized around five objectives: 1) raising awareness among the general public and healthcare professionals; 2) education; 3) research and innovation; 4) monitoring and surveillance; and 5) interministerial and international action governance. Regular One Health brochures are published, presenting a brief overview of the implemented initiatives and their impact (1,8).
The most recent sectorial operational plan in human health was released by the Ministry of Health in February 2022: the 2022–2025 national strategy for preventing infections and antibiotic resistance in human health (9). The synergy between antibiotic stewardship and infection prevention and control activities is underlined, encompassing the prevention of viral and bacterial community-acquired and healthcare-associated infections. A series of performance indicators are included, with defined targets, to monitor progress at national and regional levels.
We present below a selection of some actions conducted in human health, that might be of interest to an international readership. For more information on the other actions, annual reports and summary brochures are regularly published and available online (8,10).
Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019;19(1):56 − 66. http://dx.doi.org/10.1016/S1473-3099(18)30605-4.
[4]
European Center for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. https://atlas.ecdc.europa.eu/. [2022-10-01].
French Ministry of Solidarity and Health. Assessment of actions carried out in human health in 2021 as part of the interministerial roadmap for controlling antimicrobial resistance and the national action program for the prevention of healthcare-associated infections-Annual Report- March 2022. https://solidarites-sante.gouv.fr/IMG/pdf/rapport_annuel_ 2021_antibioresistance_vf.pdf. [2022-10-01]. (In French).
Public health France, University of Lorraine, AntibioEst, Regional Health Agency Grand Est, Primary Health Insurance Funds of Meurthe-et-Moselle, Regional Division of the North-East Medical Service. Antibio’Malin - Les antibiotiques: soyons malins, utilisons-les mieux. 2022. https://www.sante.fr/antibiomalin. [2022-04-03]. (In French).